In this RichReport slidecast, Dr. Nick New from Optalysis describes how the company's optical processing technology delivers accelerated performance for FFTs and Bioinformatics.
Our prototype is on track to achieve game-changing improvements to process times over current methods whilst providing high levels of accuracy that are associated with the best software processes.”
Earlier this week, the company raised $3.95 million U.S. dollars from angel investors. Optalysys will use the funds to manufacture the first commercially available high-performance computing processor based on its patented optical processing technology.
Podden och tillhörande omslagsbild på den här sidan tillhör
Rich Brueckner. Innehållet i podden är skapat av Rich Brueckner och inte av,
eller tillsammans med, Poddtoppen.
